The diagnostic value of 11C-Choline PET/CT in imaging prostate cancer with increasing PSA after first-line treatment has been investigated by several authors, and this technique demonstrated to be more helpful than conventional imaging modalities in the detection of lymph node and distant metastases.21–27 However, its use for primary prostate cancer remains controversial. The gene discussed is KLK3; the disease is prostate carcinoma.